Ginkgo Bioworks announced today that it agreed to acquire fungal platform technology developer Dutch DNA ahead of going public.
Last week, the Boston-based cell programming platform developer announced that it was combining with Soaring Eagle Acquisition Corp. to go public. The SPAC values Ginkgo at $15 billion and is expected to provide up to $2.5 billion in primary proceeds, while institutional investors committed $775 million in an oversubscribed private investment in public equity, according to a news release.
Get the full story from our sister site, Drug Delivery Business.
Tell Us What You Think!